85 related articles for article (PubMed ID: 1807873)
41. Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation.
Maki N; Hoffman DR; Johnston JM
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):728-32. PubMed ID: 3422455
[TBL] [Abstract][Full Text] [Related]
42. The platelet-activating factor acetylhydrolase of mouse platelets.
Karpouza AP; Vakirtzi-Lemonias C
Biochim Biophys Acta; 1997 Jan; 1323(1):12-22. PubMed ID: 9030208
[TBL] [Abstract][Full Text] [Related]
43. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis.
Endo S; Inada K; Yamashita H; Takakuwa T; Nakae H; Kasai T; Kikuchi M; Ogawa M; Uchida K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):289-95. PubMed ID: 8008978
[TBL] [Abstract][Full Text] [Related]
44. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis.
Hemmings R; Miron P; Falcone T; Bourque J; Lepage N; Langlais J
Obstet Gynecol; 1993 Feb; 81(2):276-9. PubMed ID: 8423963
[TBL] [Abstract][Full Text] [Related]
45. Application of gel permeation HPLC for lipoprotein profiling in dogs.
Mizutani H; Sako T; Arai N; Kuriyama K; Yoshimura I; Mori A; Iwase K; Hirose H
J Vet Med Sci; 2010 Jun; 72(6):813-7. PubMed ID: 20145378
[TBL] [Abstract][Full Text] [Related]
46. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s).
Akiyama M; Sugatani J; Suzuki T; Suzuki Y; Miwa M
J Biochem; 1998 May; 123(5):786-9. PubMed ID: 9562606
[TBL] [Abstract][Full Text] [Related]
47. Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction.
Serebruany VL; Gurbel PA; Murugesan SR; Lowry DR; Sturm E; Svetlov SI
Cardiology; 1998 Oct; 90(2):127-30. PubMed ID: 9778550
[TBL] [Abstract][Full Text] [Related]
48. Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis.
Iatrou C; Moustakas G; Antonopoulou S; Demopoulos CA; Ziroyiannis P
Nephron; 1996; 72(4):611-6. PubMed ID: 8730430
[TBL] [Abstract][Full Text] [Related]
49. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
50. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis.
Graham RM; Stephens CJ; Silvester W; Leong LL; Sturm MJ; Taylor RR
Crit Care Med; 1994 Feb; 22(2):204-12. PubMed ID: 8306677
[TBL] [Abstract][Full Text] [Related]
51. Serum amyloid A (ApoSAA) and lipoproteins.
Eriksen N; Benditt EP
Methods Enzymol; 1986; 128():311-20. PubMed ID: 3724509
[No Abstract] [Full Text] [Related]
52. Chromatographic depletion of lipoproteins from plasma and recovery of apolipoproteins.
Carson SD
Biochim Biophys Acta; 1983 Feb; 750(2):317-21. PubMed ID: 6407529
[TBL] [Abstract][Full Text] [Related]
53. Fractionation of plasma lipoproteins: evaluation of preparative methods.
Ferreri LF
Lab Res Methods Biol Med; 1984; 10():133-56. PubMed ID: 6390048
[No Abstract] [Full Text] [Related]
54. The mouse plasma PAF acetylhydrolase: I. Characterization and properties.
Tsaoussis V; Vakirtzi-Lemonias C
J Lipid Mediat Cell Signal; 1994 May; 9(3):301-15. PubMed ID: 7921789
[TBL] [Abstract][Full Text] [Related]
55. High-performance liquid chromatography of apolipoproteins.
Edelstein C; Scanu AM
Methods Enzymol; 1986; 128():339-53. PubMed ID: 3724511
[No Abstract] [Full Text] [Related]
56. Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins.
Alaupovic P
Methods Enzymol; 1996; 263():32-60. PubMed ID: 8748999
[No Abstract] [Full Text] [Related]
57. Gauging cardiovascular risk with the PLAC test.
Brown RA
Nursing; 2006 Aug; 36(8):17. PubMed ID: 16888484
[No Abstract] [Full Text] [Related]
58. Serum platelet-activating factor acetylhydrolase activity in patients with atopic dermatitis.
Ohnishi T; Watanabe S; Kobayashi M; Sugimoto M; Yamada K; Yamaoka K; Kinoshita M
J Dermatol Sci; 2003 Oct; 33(1):70-2. PubMed ID: 14527741
[No Abstract] [Full Text] [Related]
59. Delipidation of plasma lipoproteins.
Osborne JC
Methods Enzymol; 1986; 128():213-22. PubMed ID: 3724503
[No Abstract] [Full Text] [Related]
60. Sequential flotation ultracentrifugation.
Schumaker VN; Puppione DL
Methods Enzymol; 1986; 128():155-70. PubMed ID: 3724500
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
